Trials
Search / Trial NCT05639452

Development of an Early Warning Score for Detecting the Deterioration of a Patients' General Condition in an Acute Hospital

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Nov 28, 2022

Apply for Trial

Trial Information

Current as of January 13, 2025

Completed

Keywords

Early Warning Score (Ews) Deterioration Of Patients' General Condition

ClinConnect Summary

An acute deterioration of a patients' general condition is often preceded by changes in individual vital parameters and may lead to adverse events, such as admission to the intensive care unit, heart attack or death. Some of them are potentially avoidable if appropriate measures are taken in a timely manner. Therefore early warning systems (Early Warning Scores= EWS) have been developed from a set of several physiological measurements, signs and symptoms. Individual parameters are weighted to sum up a score.

Based on this score, the deterioration of a patients' general condition may be ind...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Hospitalized patients of surgical and medical wards of University Hospital Basel
  • • Hospital stay longer than 24 hours
  • • Signed general consent
  • Exclusion Criteria:
  • • Patients admitted directly to the intensive care unit
  • • Rejection of general consent

Trial Officials

Jens Eckstein, Prof. Dr. med.

Principal Investigator

University Hospital Basel, Division of Internal Medicine

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, , Switzerland

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials